Manufacturer record
Pharma Cure Laboratories: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Pharma Cure Laboratories (Punjab) were declared Not of Standard Quality between March 2025 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AS-1460, Atropine Sulphate Injection I.P (Curopine) (exp Dec 2026). State Lab Karnataka (state lab) found it not of standard quality: Sterility. Listed in the June 2025 alert.
Records by type
3 records linked to Pharma Cure Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Atropine Sulphate Injection I.P (Curopine) | Batch AS-1460Mfg Jan 2025 · Exp Dec 2026 | SterilitySterility | State Lab KarnatakaState lab | Jun 2025 |
| Vitamin C, Vitamin B12, Folic Acid and Niacinamide Injection (Curevit-12 (Combi Pack)) | Batch CP-937Mfg Dec 2024 · Exp May 2026 | Particulate Matter and DescriptionDescription | CDL, KolkataCDSCO lab | Mar 2025 |
| Tranexamic Acid Injection I.P. (Tranexacure Injection) | Batch TC-038Mfg Dec 2024 · Exp Nov 2026 | Particulate Matter and DescriptionDescription | CDL, KolkataCDSCO lab | Mar 2025 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| L-Carnitine, L- Tartarate ,Mecobalamin & Folic Acid Tablets | B95Y032 | SDTL, Assam | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Apr 2026 |
| Trypsin-Chymotrypsin Tablets | 2KU6L055 | FDAL Maharashtra | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Jan 2026 |
| Deflazacort Tablets 6 mg Defcort 6 | 13240334A | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.